Category Archives: "INforMS"

Elevated BMI: a modifiable risk factor for multiple sclerosis?
Individuals with genetically increased body mass indexes were at a greater risk for developing multiple sclerosis (MS), according to [...]
Scientists develop a drug for the treatment of multiple sclerosis
A team of scientists has created a new form of a vaccine used for the treatment of multiple sclerosis, one of the most severe [...]
Micro-RNA levels may be diagnostic marker, distinguishing multiple sclerosis from other diseases
Patients with multiple sclerosis (MS) have higher levels of a micro-RNA called miR-150 in their cerebrospinal fluid, a liquid surrounding [...]
Multiple sclerosis-related optic neuropathy can be reversed with allergy drug (antihistamine): study
Multiple sclerosis-related optic neuropathy can be reversed with allergy drugs (antihistamines), according to research. The preliminary [...]
Multiple sclerosis development: what is clinically isolated syndrome (CIS)?
1. What is Clinically Isolated Syndrome? Clinically isolated syndrome (CIS) is often a sign of multiple sclerosis and the term refers to [...]
Four new risk genes associated with multiple sclerosis discovered
Scientists of the Technical University of Munich (TUM) and the Max Planck Institute of Psychiatry have identified four new risk genes that [...]
Clinical pilates seen to improve both cognition and muscle strength in multiple sclerosis patients
Clinical pilates can improve cognitive skills and life quality in multiple sclerosis (MS) patients, in addition to helping them physically. [...]
Sleep impacts cognitive function in multiple sclerosis patients
Obstructive sleep apnea and sleep disturbances are linked to diminished cognitive ability in patients with multiple sclerosis (MS), [...]
How does menopause affect women with multiple sclerosis?
Although menopause occurs in every woman who lives long enough, very little research has been done on its effects on women with multiple [...]
Gray matter atrophy tied to specific disabilities in multiple sclerosis
Specific disabilities in multiple sclerosis (MS) were associated with voxelwise gray matter loss in distinct locations, a cross-sectional [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM